SIDNEY KIMMEL CANCER CENTER

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 1254
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8781750 Cell-type-specific patterns of gene expressionJan 10, 05Jul 15, 14[C12Q, G01N]
5681562 Lymphokine gene therapy of cancerDec 09, 94Oct 28, 97[A61K, C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8349555 Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signaturesExpiredMar 16, 06Jan 08, 13[C12Q]
2011/0173,709 ECTOPIC, ORTHOTOPIC MODEL FOR REVASCULARIZATION AND TUMOR ASSESSMENTAbandonedFeb 29, 08Jul 14, 11[A61K, A01K, A61P]
2007/0167,405 Galectins -1 and -4 in tumor developmentAbandonedJul 05, 06Jul 19, 07[A61K, G01N]
2006/0286,074 Methods for immunotherapy of cancerAbandonedMay 26, 06Dec 21, 06[A61K, C07H, C12N, C07K]
2006/0024,232 Imaging and therapeutic agents targeting proteins expressed on endothelial cell surfaceAbandonedJun 02, 05Feb 02, 06[A61K]
2006/0024,315 Vascular targets for detecting, imaging and treating neoplasia or neovasculatureAbandonedJun 02, 05Feb 02, 06[A61K]
2005/0032,728 Tumor suppression through bicistronic co-expression of p53 and p14ARFAbandonedNov 19, 03Feb 10, 05[A61K, C12N]
2004/0115,128 Targeting endothelium for tissue-specific delivery of agentsAbandonedJul 31, 03Jun 17, 04[A61K, C12Q, G01N]
2004/0053,317 Gene segregation and biological sample classification methodsAbandonedSep 10, 03Mar 18, 04[C12Q]
2003/0224,382 Reduced complexity nucleic acid targets and methods of using sameAbandonedNov 07, 02Dec 04, 03[C12Q]
2003/0212,021 Myeloid colony stimulating factor and uses thereofAbandonedNov 26, 02Nov 13, 03[A61K, C12N]
2003/0109,464 Galectins -1 and -4 in tumor developmentAbandonedSep 30, 02Jun 12, 03[A61K, G01N]
2003/0008,819 Targeting endothelium for tissue-specific delivery of agentsAbandonedJan 24, 02Jan 09, 03[A61K]
6495319 Reduced complexity nucleic acid targets and methods of using sameExpiredApr 27, 99Dec 17, 02[C07H, C12Q, G01N]
2002/0006,413 Genetically engineered tumor cell vaccinesAbandonedJan 26, 01Jan 17, 02[A61K]
6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibodyExpiredDec 14, 98Nov 14, 00[C07K]
6054467 Down-regulation of DNA repair to enhance sensitivity to P53-mediated apoptosisExpiredJul 05, 96Apr 25, 00[A61K, A01N]
5849583 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related diseaseExpiredAug 20, 93Dec 15, 98[C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.